Business Context and Reporting Period
This Form 8-K was filed by Inpixon (not XTI Aerospace, Inc.) on May 17, 2018. The registrant is a Nevada corporation headquartered in Palo Alto, California, and is classified as an emerging growth company. The report addresses regulatory compliance issues with the Nasdaq Stock Market and amendments to the company's employee compensation plans.
Key Financial Metrics
The filing does not provide specific financial statements, revenue, profit, cash flow, or debt figures. The only quantitative financial metric disclosed is the stock price performance triggering the regulatory notice:
- Minimum Bid Price Requirement: $1.00 per share.
- Observed Price: The closing bid price remained below $1.00 for 30 consecutive business days (April 5, 2018, to May 16, 2018).
Material Changes and Events
Nasdaq Delisting Notice (Item 3.01)
Inpixon received a notice from Nasdaq indicating non-compliance with Listing Rule 5550(a)(2) due to the low stock bid price. The company has been granted a 180-day compliance period ending November 13, 2018, to regain compliance. To cure the deficiency, the stock must close at or above $1.00 for 10 consecutive business days within this window. Failure to comply may result in delisting, though a second 180-day period may be available if the company meets other listing standards and effects a reverse stock split.
Compensation Plan Amendments (Item 5.02)
The Board of Directors adopted Amendment No. 1 to the 2018 Employee Stock Incentive Plan. Key changes include:
- Reducing the aggregate fair market value limit for incentive stock options to $100,000 to comply with Internal Revenue Code Section 422.
- Removing the limit on the number of non-qualified stock options that can be issued under the plan.
- Adopting new forms for incentive and non-qualified stock option agreements.
Outlook, Risks, and Management Commentary
Management intends to monitor the stock price and consider available options, including a potential reverse stock split, if the price remains below the $1.00 threshold. The filing explicitly states there can be no assurance that the company will regain compliance with the minimum bid price requirement or maintain other listing requirements. Immediate delisting is not occurring, but the risk of future delisting exists if the deficiency is not cured by the November 13, 2018 deadline.
Investor Verification Checklist
- Verify the current trading price of Inpixon stock to assess the likelihood of meeting the $1.00 bid price requirement within the 180-day window.
- Monitor future filings for announcements regarding a reverse stock split or other capital structure changes intended to cure the deficiency.
- Review the attached exhibits (4.1, 10.1, 10.2) to understand the specific terms of the amended stock option plan and potential dilution effects.
- Confirm the company's status regarding other Nasdaq listing standards (e.g., market value of publicly held shares) to determine eligibility for a second compliance period if needed.